COMPUMEDICS LIMITED — Earnings Release 2014

Jul 2, 2014

ASX Announcement 3 July 2014

==> picture [102 x 86] intentionally omitted <==

Business Update – Preliminary Indicative 30 June 2014 Guidance

• Preliminary revenues for 30[th] June 2014, at $30m, approximately 10% higher than FY2013

• Preliminary results indicate a return to profitability for year to 30 June 2014

• Cloud-­‐based sleep diagnostic and monitoring platform (eHealth) potential business incremental to the existing business

Compumedics Limited (ASX: CMP) is pleased to announce, for the year ended 30[th] June 2014, preliminary results indicate the Company will return to profitability having shipped and invoiced approximately $30m in sales. Final results will be subject to audit commencing later this month, with the Appendix 4E to be released to the Australian Stock Exchange (ASX) later in August.

In delivering this result the Company has ended 30[th] June 2014 with sales-­‐orders on-­‐hand of about $5.6m, reflecting a strong run of new sales orders into the business through to the end of the financial year.

Further the results reflect the on-­‐going positive outcomes from the Company’s continuing process of transforming and relocating key manufacturing activities to lower cost countries.

Together with the lower dollar, relative to twelve months ago, these activities will continue to impact positively on the business moving forward.

The announcement to the ASX yesterday (2[nd] July 2014), regarding the cloud-­‐based sleep diagnostic and monitoring platform (eHealth) contracts secured recently, reflects incremental and new business to the Company.

That is, this potential revenue and income stream will be in addition to the Company’s existing business on which guidance has been given today.

The Company see’s this opportunity as highly complementary to the Company’s existing business and a new and incremental market to leverage its significant technology in sleep diagnostics into.

**About

Compumedics Limited**

Compumedics Limited (ASX: CMP) is a medical device company involved in the development, manufacture and commercialisation of diagnostics technology for the sleep, brain and ultrasonic blood-­‐flow monitoring applications. The Company owns US based Neuroscan and Germany basedDWL Elektronishe GmbH. In conjunction with these two subsidiaries, Compumedics has a broad international reach, including Americas; Australia and Asia Pacific; and Europe and the Middle East.

Executive Chairman, Dr David Burton, founded Compumedics in 1987. In the same year the Company successfully designed and installed the first Australian, fully computerised Sleep Clinic at Epworth Hospital in Melbourne. Following this early success, Compumedics focused on the development of products that sold into the growing international sleep clinic and home monitoring markets. Compumedics listed on the Australian Securities Exchange in 2000. Over the years, Compumedics has received numerous awards and accolades including Australia’s exporter of the year and has been recognised as a Top 100 Innovatorby the both German and Australian Governments.

**For

further information please contact:**

Dr David Burton , Executive Chairman, CEO Compumedics Limited T: + 61 3 8420 7300, F: +61 3 8420 7399

Mr David Lawson , Executive Director, CFO Compumedics Limited T: + 61 3 8420 7300, F: +61 3 8420 7399

For investor relations and media enquiries please contact:

Rod North , Managing Director, Bourse Communications Pty Ltd T: (03) 9510 8309, M: 0408 670 706 E: rod@boursecommunications.com.au